120 related articles for article (PubMed ID: 15706137)
1. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on the discrimination of durations: evidence for the involvement of 5-HT2A but not 5-HT3 receptors.
Asgari K; Body S; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
Behav Pharmacol; 2005 Feb; 16(1):43-51. PubMed ID: 15706137
[TBL] [Abstract][Full Text] [Related]
2. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
[TBL] [Abstract][Full Text] [Related]
3. Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.
Asgari K; Body S; Bak VK; Zhang ZQ; Rickard JF; Glennon JC; Fone KC; Bradshaw CM; Szabadi E
Behav Pharmacol; 2006 Feb; 17(1):51-9. PubMed ID: 16377963
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
Smith RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1995 Nov; 275(2):1050-7. PubMed ID: 7473132
[TBL] [Abstract][Full Text] [Related]
5. Effects of a 5-HT2 receptor agonist, DOI (2,5-dimethoxy-4-iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule.
Body S; Kheramin S; Ho MY; Miranda F; Bradshaw CM; Szabadi E
Behav Pharmacol; 2003 Dec; 14(8):599-607. PubMed ID: 14665977
[TBL] [Abstract][Full Text] [Related]
6. 5-HT receptors on identified Lymnaea neurones in culture: pharmacological characterization of 5-HT3 receptors.
Walcourt-Ambakederemo A; Winlow W
Gen Pharmacol; 1995 May; 26(3):553-61. PubMed ID: 7789728
[TBL] [Abstract][Full Text] [Related]
7. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release.
Smith RL; Gresch PJ; Barrett RJ; Sanders-Bush E
Pharmacol Biochem Behav; 2002 May; 72(1-2):77-85. PubMed ID: 11900772
[TBL] [Abstract][Full Text] [Related]
8. Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats.
Mazzola-Pomietto P; Aulakh CS; Murphy DL
Psychopharmacology (Berl); 1995 Oct; 121(4):488-93. PubMed ID: 8619014
[TBL] [Abstract][Full Text] [Related]
9. Central 5-HT(3) receptors and water intake in rats.
Castro L; Varjão B; Maldonado I; Campos I; Duque B; Fregoneze J; Reis de Oliveira I; De Castro-e-Silva E
Physiol Behav; 2002 Nov; 77(2-3):349-59. PubMed ID: 12419412
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
Hemrick-Luecke SK; Evans DC
Neuropharmacology; 2002 Feb; 42(2):162-9. PubMed ID: 11804612
[TBL] [Abstract][Full Text] [Related]
12. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
Alhaider AA; Ageel AM; Ginawi OT
Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
[TBL] [Abstract][Full Text] [Related]
13. Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors.
Body S; Cheung TH; Bezzina G; Asgari K; Fone KC; Glennon JC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2006 Dec; 189(3):331-43. PubMed ID: 17051415
[TBL] [Abstract][Full Text] [Related]
14. Effects of fenfluramine on free-operant timing behaviour: evidence for involvement of 5-HT2A receptors.
Body S; Kheramin S; Ho MY; Miranda Herrera F; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2004 Nov; 176(2):154-65. PubMed ID: 15103450
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of 5-HT3 receptor function by the activation of coexistent 5-HT2 receptors in trigeminal ganglion neurons of rats.
Hu WP; Guan BC; Ru LQ; Chen JG; Li ZW
Neuropharmacology; 2004 Nov; 47(6):833-40. PubMed ID: 15527817
[TBL] [Abstract][Full Text] [Related]
16. Central 5-HT2B/2C and 5-HT3 receptor stimulation decreases salt intake in sodium-depleted rats.
Castro L; Athanazio R; Barbetta M; Ramos AC; Angelo AL; Campos I; Varjão B; Ferreira H; Fregoneze J; de Castro e Silva E
Brain Res; 2003 Aug; 981(1-2):151-9. PubMed ID: 12885436
[TBL] [Abstract][Full Text] [Related]
17. The reinforcing actions of a serotonin-3 receptor agonist within the ventral tegmental area: evidence for subregional and genetic differences and involvement of dopamine neurons.
Rodd ZA; Gryszowka VE; Toalston JE; Oster SM; Ji D; Bell RL; McBride WJ
J Pharmacol Exp Ther; 2007 Jun; 321(3):1003-12. PubMed ID: 17325230
[TBL] [Abstract][Full Text] [Related]
18. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
[TBL] [Abstract][Full Text] [Related]
19. Evidence that the effect of 5-HT2 receptor stimulation on temporal differentiation is not mediated by receptors in the dorsal striatum.
Body S; Asgari K; Cheung TH; Bezzina G; Fone KF; Glennon JC; Bradshaw CM; Szabadi E
Behav Processes; 2006 Feb; 71(2-3):258-67. PubMed ID: 16326032
[TBL] [Abstract][Full Text] [Related]
20. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.
Ponzoni A; Monti JM; Jantos H
Eur J Pharmacol; 1993 Nov; 249(3):259-64. PubMed ID: 8287912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
